Long-Term Use Semaglutide: Has shown promise for long-term weight management, but continuous use is required to maintain weight loss
Retatrutides 24.2% average weight loss at 48 weeks approaches the results typically achieved through bariatric surgery, which produces 25-30% weight loss
Keep Reading Medical Weight Loss: How to Administer At-Home Injections
The risk of dosing errors, infection, and serious adverse reactions is substantial without professional oversight and clinical monitoring
Whether this has clinical significance is unknown, but researchers who track their results closely often notice more consistent appetite suppression and energy levels when they maintain consistent injection sites
The clinical trials for tirzepatide reported that GI side effects were the primary reason patients discontinued treatment, and those rates increased at higher doses